News & Perspective

Nov 04, 2010

Nov 04, 2010

Grants for small biotechs include infectious-disease projects

(CIDRAP News) – Federal officials announced yesterday that $1 billion worth of grants and tax credits will be awarded to thousands of small biotechnology companies to support the development of new medical therapies, including a number of products for infectious diseases.

Sep 29, 2010

Sep 29, 2010

Sebelius envisions cell-based flu vaccine in 2011

(CIDRAP News) – Speaking at a Senate committee hearing today, US Health and Human Services (HHS) Secretary Kathleen Sebelius said a cell-based seasonal influenza vaccine from Novartis could be on the US market in time for the 2011-12 flu season.

Sep 15, 2010

Sep 15, 2010

Pending injury claims over 2009 H1N1 vaccine increase

(CIDRAP News) – The number of people who intend to submit claims that they were harmed by the 2009 H1N1 influenza vaccine has grown to 275 in recent months, but the procedures for processing the claims have not yet been fully worked out, according to the US Department of Health and Human Services (HHS).

Aug 19, 2010

Aug 19, 2010

HHS sees greater federal role in building biodefense tools

(CIDRAP News) – Federal health officials, in releasing today a blueprint for overhauling the nation's civilian biodefense program, called for increased government partnerships with the private sector and a number of innovative steps to boost the development of medical countermeasures (MCMs) that have little or no commercial market.

Aug 19, 2010

Obama's science advisors outline plan for faster pandemic vaccine

(CIDRAP News) – In light of vaccine production problems that delayed the delivery of the pandemic H1N1 vaccine, a report by President Barack Obama's science advisers released today said targeted investments in five specific areas could trim the time needed to quickly produce enough to protect the nation by weeks or months.

Jul 27, 2010

Jul 27, 2010

Federal advisors hope to build on H1N1 vaccine safety-monitoring lessons

(CIDRAP News) – Over the next few months, the nation's healthcare providers will shift from giving the pandemic H1N1 vaccine to a seasonal flu vaccine that contains the new virus, which has federal officials grappling with how to transition from a massive vaccine monitoring effort to a likely more routine system for the seasonal version.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»